Solutions
- - Healthcare Professionals
  - - H1 Connect
      
      Connecting Doctors and NGOs to empower medical missions and humanitarian work worldwide.
      
      Learn more
How We Help
- - By Customer
  - Pharmaceutical & Biotechnology
  - Payors
  - Healthcare Professionals
- - Featured
  - - Empowering Medical and Commercial Teams with Data Insights
      
      In Conversation with Katie Shin, Sr. Global Director of Field Medical and Scientific Affairs, Sumitomo Pharma America
      
      Learn More
Customers
Resources
Company
- - What’s New
  - Press
  - Events
  - Get in Touch
  - Contact Us
- - Featured Press
  - - H1 Expands Trial Landscape with U.K. Diversity Data to Enhance Clinical Trial Equity and Meet Evolving Regulatory Standards
      
      Learn More
Request a Demo
Login

Request a Demo Login

Blog

Read the latest perspectives from our team of subject matter experts and others

doctor speaking with patient

FDA Poised to Make Impact on Underrepresented Populations in Clinical Studies

Diversity Action Plans (DAPs) aim to improve data that the FDA receives by increasing the clinical enrollment of historically underrepresented participants. Increasing diversity in clinical trials not only makes the… Continue reading →

Read the article

Post Topics:

Artificial Intelligence

Commercialization

Diversity & Inclusion

Drug Development

Global Impact

HCP Volunteers

KOL Engagement

Provider Data

Research

Post Industries:

Commercialization

Global Impact

Payors

Pharmaceutical & Biotechnology

Provider Data

Research

Artificial Intelligence KOL Engagement Provider Data
A Holistic Approach to Measuring Impact
Medical Affairs plays an essential role in evidence-based medicine, disease education, and driving better outcomes. Their knowledge is crucial as medications become more specialized and complex. They enable healthcare… Continue reading →

Read the article
no
Artificial Intelligence Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
Trials, Data, Diversity – H1’s Top 5 Diagnoses (Predictions) for Biotech and Pharma in 2024
How will AI impact clinical trials? Will FDA legislation improve diversity? What platforms will key opinion leaders adopt? Every year, we take a look at annual predictions to help life… Continue reading →

Read the article
no
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
H1 Honored with a Spot on Y Combinator’s 2023 Best Companies List and Slice of Healthcare’s Inaugural Digital Health Leaders List
H1, the connecting force for global healthcare provider, clinical, science, and research information, today announced that it has been recognized in two prestigious annual lists: Y Combinator’s 2023 Best Companies… Continue reading →

Read the article
no
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
New Look, Same Commitment!
I’m excited to officially unveil the new branding and website our team has been working on for several months. This new branding comes with much thought and consideration, and reflects… Continue reading →

Read the article
no
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
Timmy Awards Announces H1 as 2022 Tech for Good Finalist
The 8th Annual Timmy Awards run by Tech in Motion celebrates leaders in tech, recognizing the top workplaces for tech professionals across North America. We are thrilled to announce that H1 is… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
The Evolution of H1’s Core Values
I remember it clearly. Me, Ian – our co-founder and a handful of brave individuals who would become the first H1 employees, sitting around a table writing down the values… Continue reading →

Read the article
Provider Data
Healthcare Innovation Needs Foundational Provider Data First
In the age of voice-activated smart speakers, phones and technology, very soon making a doctor’s appointment or finding a new doctor will be as simple as speaking the words. This… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
H1 Recognized as One of Forbes’ Best Startup Employers 2022
H1, which provides the largest global healthcare professional data ecosystem to enable life sciences, academic medical institutions, health systems, and payers, today announced it has been included on Forbes’… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
H1 Named to NYC Digital Health 100 by NYCHBL
H1, which provides the largest global healthcare platform that connects healthcare professionals, today announced that New York City Health Business Leaders (NYCHBL), the organization that serves as the gateway to… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
H1 Wraps Up 2021 with Gratitude
2021 was a year of enormous change around the world, as we learn to live and work in new ways. For H1, it was also a year of enormous growth,… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
Co-Founder and CEO of H1 Named to Forbes 30 Under 30
H1 announced today that its CEO and Co-Founder Ariel Katz was named to the prestigious Forbes 30 under 30 list. Ariel started his first company in college, ResearchConnection, to help… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
Ziad Ismail Joins H1 During Period of High Growth
H1, which provides the largest global healthcare network that connects healthcare professionals, announced today that it has added Ziad Ismail to the management team as Chief Operating Officer. Ziad… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
H1 Raises Series C
Today we announced our Series C of $100 million led by Altimeter and participation from new investors including Goldman Sachs Asset Management and Flex Capital. It also includes the support… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
Former Dropbox CIO Joins Board of Healthcare Data Startup H1
Board member Sylvie Veilleux (Salesforce, Dropbox), CFO Karen Moran (Alteryx, Domo) and CDO Mayur Thakur (Goldman Sachs, Google) bring decades of experience and add bench strength as H1 expands.… Continue reading →

Read the article
KOL Engagement Provider Data
Connecting the Dots between Patients, Physicians and Payors
Successful engagement of external experts ranks very high on the list of challenges medical affairs professionals face. No surprise here, building relationships that support long-term engagement is hard under… Continue reading →

Read the article
Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
H1 Closes $58 Million Series B Funding
Today, H1 announced a $58 million Series B round of funding to continue working towards our mission of creating a healthier future by connecting parties in the healthcare ecosystem.… Continue reading →

Read the article

Creating a
Healthier Future

Platform

H1

Products

HCP Universe
Trial Landscape
Precise
H1 Connect

About

About H1
Culture
Press
Events
Join Our Team
Login

Contact

Contact Us
Product Support

Social

Facebook Twitter LinkedIn Instagram

© H1 2024 All Rights Reserved Terms of Use Privacy Policy

Welcome

Choose your account below to login.

HCP Universe
Trial Landscape

Don't have an account? Request a demo.

✕